Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05176925
What this trial is testing

Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Fudan University 5
Large-scale testing (Phase 3)Study completedNCT00144989
What this trial is testing

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Who this might be right for
Small-Cell-Lung Cancer
Haruhiko Fukuda 281
Post-approval studies (Phase 4)Looking for participantsNCT06330038
What this trial is testing

Anesthesia and Non-small Cell Lung Cancer Recurrence

Who this might be right for
Non-small Cell Lung CancerSurgeryAnesthesia
Samsung Medical Center 5,384
Testing effectiveness (Phase 2)UnknownNCT05458726
What this trial is testing

Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC

Who this might be right for
EGFR T790MOsimertinibNon-small Cell Lung Cancer+1 more
Peking Union Medical College 80
Not applicableStudy completedNCT00899535
What this trial is testing

Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 70
Post-approval studies (Phase 4)UnknownNCT01665417
What this trial is testing

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Who this might be right for
EGFR Positive Non-small Cell Lung CancerAdenocarcinoma
Betta Pharmaceuticals Co., Ltd. 100
Early research (Phase 1)Ended earlyNCT04892017
What this trial is testing

Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerAdvanced Solid TumorMetastatic Solid Tumor
Deciphera Pharmaceuticals, LLC 91
Testing effectiveness (Phase 2)Looking for participantsNCT07276789
What this trial is testing

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Integro Theranostics 35
Not applicableStudy completedNCT04187768
What this trial is testing

Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticHealthy
Indiana University 29
Large-scale testing (Phase 3)Ended earlyNCT00345059
What this trial is testing

The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
National Cancer Institute, Naples 84
Not applicableLooking for participantsNCT07528066
What this trial is testing

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Who this might be right for
Neoadjuvant ChemoimmunotherapyRobotic Pulmonary ResectionStage IIB-III NSCLC
Shanghai Chest Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00702962
What this trial is testing

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Milton S. Hershey Medical Center 8
Not applicableStudy completedNCT03925103
What this trial is testing

Assessment of Ergonomics in 3D vs 2D Thoracoscopic Lobectomy

Who this might be right for
Early Stage Non-small-cell Lung Cancer (Stage 1-2)
University of Rome Tor Vergata 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07355231
What this trial is testing

Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Xemed LLC 10
Early research (Phase 1)Study completedNCT00560573
What this trial is testing

Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 46
Early research (Phase 1)Looking for participantsNCT07181473
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Lung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more
Phrontline Biopharma 200
Testing effectiveness (Phase 2)Study completedNCT00470054
What this trial is testing

Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 44
Not applicableNot Yet RecruitingNCT06922266
What this trial is testing

Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ospedale San Raffaele 20
Not applicableNot Yet RecruitingNCT07661251
What this trial is testing

ITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)

Who this might be right for
Non-Small Cell Lung Cancer
Laura Longshaw 60
Testing effectiveness (Phase 2)UnknownNCT03201146
What this trial is testing

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Who this might be right for
Lung CancerNon Small Cell Lung CancerCombination Chemotherapy+1 more
West China Hospital 48
Next Page